About 1.9 million people in the U.S. have type 1 diabetes mellitus (T1DM), a chronic autoimmune condition that increases the risk of serious complications and affects quality of life. New technologies can improve glycemic control for patients requiring multiple insulin injections daily, but healthcare providers (HCPs) often struggle to create personalized treatment plans using these devices. This activity will feature expert speakers who will: Evaluate new technologies for managing T1DM, including glucose monitoring and automated insulin delivery systems for both adults and children. Discuss how to select and implement diabetes technology for personalized treatment plans. Address barriers to using diabetes technology and emphasize the importance of patient education and shared decision-making for optimal T1DM management.
- Provider:Endocrine Society
- Activity Link: https://education.endocrine.org/URL/Diabetes_Tech_Enduring
- Start Date: 2024-10-11 05:00:00
- End Date: 2024-10-11 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 1.0 hours
- MOC Credit Details: ABIM - 1.0 Point; Credit Type(s): Medical Knowledge (ABIM)
- Commercial Support: Source: Mannkind - Amount: 35000.0 - Is Kind Support: False Source: Medtronic - Amount: 10000.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Competence, Learner Knowledge, Learner Performance
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Endocrinology, Diabetes, and Metabolism